Dean Schorno
Directeur Financier/CFO chez RIGEL PHARMACEUTICALS, INC.
Fortune : 331 176 $ au 30/06/2024
Postes actifs de Dean Schorno
Sociétés | Poste | Début | Fin |
---|---|---|---|
RIGEL PHARMACEUTICALS, INC. | Directeur Financier/CFO | 29/05/2018 | - |
Historique de carrière de Dean Schorno
Anciens postes connus de Dean Schorno
Sociétés | Poste | Début | Fin |
---|---|---|---|
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Directeur des opérations | 17/08/2015 | 01/05/2018 |
Directeur Financier/CFO | 17/08/2015 | 01/05/2018 | |
ADAPTIVE BIOTECHNOLOGIES CORPORATION | Directeur Financier/CFO | 24/06/2014 | 10/08/2015 |
GENOMIC HEALTH, INC. | Directeur Financier/CFO | 10/01/2011 | 01/07/2014 |
Investor Relations Contact | 01/07/2003 | 01/07/2014 | |
Public Communications Contact | 01/07/2003 | 01/07/2014 | |
Corporate Officer/Principal | 01/02/2010 | 10/01/2011 |
Formation de Dean Schorno
University of California, Berkeley | Undergraduate Degree |
Golden Gate University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Opérationnelle
Director of Finance/CFO | 4 |
Investor Relations Contact | 1 |
Public Communications Contact | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
RIGEL PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Genomic Health, Inc.
Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
- Bourse
- Insiders
- Dean Schorno
- Expérience